Non-peptide CCR1 receptor antagonists for the treatment of progressive renal fibrosis
US6812230B2 · kind B2 · utility
5Cited by
3References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 26, 2002 |
| Grant date | Nov 2, 2004 |
| Priority date | — |
| Expiry date | Jul 31, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to pharmaceutical compositions useful in treating progressive renal fibrosis in mammals comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a non-peptide CCR1 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.